CELG News and Press, Celgene Corporation From 05/21/19

“Brain Bulb” Hot Air Balloon Takes Flight in NYC Area to Elevate Importance of Brain Preservation Celgene Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association of America (MSAA) today announced the launch of a new campaign, MS MindShift: A New View of MS ,...

This article is part of a series that provides an ongoing analysis of the changes made to Prem Watsa’s 13F portfolio on a quarterly basis. It is based on Watsa’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Prem Watsa’s Fairfax Financial Holdings P...

This article is part of a series that provides an ongoing analysis of the changes made to George Soros’s 13F stock portfolio on a quarterly basis. It is based on George Soros’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Soros Fund Management Holdings ...

May 19, 2019 Palm Beach, FL – May 20, 2019  – The Electrophysiology marketplace is: “… set for explosive growth” says an industry publication .  It stated: “In the world of cardiovascular devices, growth is generally created b...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Retailers cap off the Q1 earnings season in style as Target (TGT), Best Buy (BBY), ...

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarman's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Seth Klarman's Baupost Group Holdings article for a...

Each quarter, I spend some time reading Form 13F filings from the hedge funds that specialize in merger arb, documenting, and analyzing which M&A stocks the funds have bought and which ones they haven't. I then compile the top 10 stocks held in these funds and share the results with the ...

Morphosys AG (NASDAQ: MOR ) announces  the successful outcome of a Phase 2 clinical trial, L-MIND , evaluating lead candidate MOR208, combined with Celgene's (NASDAQ: CELG ) Revlimid (lenalidomide), in patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) who are ...

(Source: imgflip ) Long-time readers will know that I'm a passionate value investor, always looking to buy quality companies for my retirement portfolio (100% of my life savings) at discounts to fair value. Because as Buffett famously said, " it's far better to buy a wonderful company a...